Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(4S,7S)-4-sec-butyl-7-((R)-1-hydroxyethyl)-13-isopropyl-2,5,8,11,14,15-hexaoxo-3,6,9,12,16-pentaazanonadecan-19-oic acid
ID: ALA3326345
PubChem CID: 118711580
Max Phase: Preclinical
Molecular Formula: C23H39N5O9
Molecular Weight: 529.59
Molecule Type: Small molecule
This compound is available for customization.
Associated Items: